Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy

Avaí Bio and Austrianova completed viral and adventitious-agent testing for the Master Cell Bank and established a Working Cell Bank for their α-Klotho therapy. The manufacturing-quality milestone supports further development of the therapy, but the announcement contains no clinical efficacy data, regulatory approval, financial metrics, or commercialization timeline.